MCI
REGN icon

MRP Capital Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

MRP Capital Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3
Closed -$1.57K – 218
2025
Q3 		$1.57K Hold
3
– – ﹤0.01% 196
2025
Q2 		$1.57K Sell
3
-21
-88% -$11.7K ﹤0.01% 178
2025
Q1 		$15.2K Hold
24
– – 0.01% 164
2024
Q4 		$17.1K Sell
24
-870
-97% -$730K 0.02% 155
2024
Q3 		$940K Buy
894
+603
+207% +$671K 0.89% 42
2024
Q2 		$306K Buy
+291
New +$282K 0.29% 81
2023
Q3 		– Sell
-20
Closed -$14.4K – 184
2023
Q2 		$14.4K Hold
20
– – 0.01% 197
2023
Q1 		$16.4K Sell
20
-284
-93% -$214K 0.02% 173
2022
Q4 		$219K Buy
+304
New +$224K 0.24% 83

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MRP Capital Investments's REGN Position: Q4 2025 in Review

MRP Capital Investments sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 3 shares — an estimated $1.57K sold.

MRP Capital Investments first reported a position in REGN in Q4 2022 and held it in 9 quarters. The position peaked at $940K in Q3 2024. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • MRP Capital Investments reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • MRP Capital Investments sold 3 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $1.57K.
  • MRP Capital Investments first reported a position in Regeneron Pharmaceuticals in Q4 2022 and held it in 9 quarters.
  • MRP Capital Investments's Regeneron Pharmaceuticals position peaked at $940K in Q3 2024.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on MRP Capital Investments's 13F filing for Q4 2025, filed 9 Feb 2026.